Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elaprase Safety and Efficacy in Indian Patients with Hunter Syndrome
NCT05058391Phase 4Completed
- Sponsor
- Takeda
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of idursulfase in mucopolysaccharidosis type II, sponsored by Takeda. Started Apr 2022; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type II
Beyond the preview
Go deeper on NCT05058391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05058391.